Cure51
Cure51 is a Paris-based biotech startup building a global database of cancer survivors to identify new drug targets. The company has raised $16M in seed funding and collected data from over 1,500 survivors across 42 countries.
The growth story
Cure51 grew from 2 to 63 employees between 2022 and 2026, raising $16M along the way, most recently a Seed in March 2024.
About
Cure51 develops a data platform and central lab to analyze multiomic sequencing of cancer survivor samples. The company partners with oncology centers worldwide to identify therapeutic targets for aggressive cancers, starting with three types before expanding.
The startup raised $16M in March 2024 from investors including Sofinnova Partners and Xavier Niel. It has built a team of 63 people focused on engineering and data analysis, with a median tenure of 2 years.
Founders and leadership
Engineering is the largest function at Cure51, with 8 employees. The company is led by a team with backgrounds in biotech and oncology, supported by investors with deep healthcare expertise.
The Cure51 org chart
Nicolas Wolikow (Chief Executive Officer and Founder) leads 30 mapped leaders with 10 direct reports. Click +N to expand a team; names link to the person’s public profile.
Departments, and which ones grew
Headcount by function: Engineering 12 (+33% YoY), Research 11 (+10% YoY), Business Development 8 (0% YoY), Operations 5 (+67% YoY), Arts and Design 3 (+50% YoY), Program and Project Management 3 (-25% YoY).
Talent flow
Cure51 hires from biotech firms like OWKIN, Sanofi, and DNA Script, as well as tech companies like Mindmesh. Alumni have moved to healthcare and consulting roles at Novo Nordisk, Oliver Wyman, and Allucent.
Most common previous employers of Cure51 staff: Mindmesh (YC S21) (2), Qare.fr (2), Thales (2), OWKIN (2), Sanofi (2), DNA Script (2). Former Cure51 employees most often moved to EC Healthcorp Private (1), Amelis (1), Novo Nordisk (1), Oliver Wyman (1), Plenitude (1), Allucent (1).
Alumni worth knowing
Web traffic
Traffic mix: 0% direct, 0% search, 0% social, 0% paid.
What this company is made of
Most common skills at Cure51: Project Management (25), English (21), Teamwork (21), Microsoft Office (19), Python (Programming Language) (17), Management (16), Microsoft Excel (16), Data Analysis (15).
Where the team actually sits
Cure51 people are concentrated in Île-de-France, France (27), Greater Paris Metropolitan Region (15), France (5), New York, United States (1).
Search footprint
Cure51 attracts about 2 organic search visits a month. It gained 3 ranking keywords and lost 1 in the last period.
Frequently asked
Cure51 has 63 employees as of September 2026.
Cure51 has raised $16M in total, most recently a Seed round in March 2024.
Cure51 was founded in 2021 by Nicolas Wolikow, Simon Istolainen, Paloma Cejas, PhD, Alexandre SYROTA.
Nicolas Wolikow (Chief Executive Officer and Founder) sits at the top of Cure51's reporting structure, with 10 direct reports.
The most common previous employers of current Cure51 staff are Mindmesh (YC S21) (2 people), Qare.fr (2 people), Thales (2 people).
Former Cure51 employees most often move to EC Healthcorp Private (1), Amelis (1), Novo Nordisk (1).
Cure51 attracts about 2 organic search visits a month.
The most common skills among Cure51 staff are Project Management, English, Teamwork, Microsoft Office, Python (Programming Language).
Cure51 staff are concentrated in Île-de-France, France (27), Greater Paris Metropolitan Region (15), France (5).
Cure51 has about 12 people in Engineering, up 33% over the past year, as of September 2026.
Cure51 has about 11 people in Research, up 10% over the past year, as of September 2026.
Computed from 55 current and 14 former Cure51 profiles, as of September 2026. Source: Crustdata.
Build this for any company
Every number on this page came from the Crustdata API. Point the MCP at a company and get the same org chart, alumni list and talent flow in one prompt.